# EDGAR Filing Document

**Accession Number:** 0002075320
**File Stem:** 0001354457-26-000098
**Filing Date:** 2026-1
**Character Count:** 1178
**Document Hash:** 24eb598a847a4e25dc1512d250055060
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001354457-26-000098.hdr.sgml**: 20260128

**ACCESSION NUMBER**: 0001354457-26-000098

**CONFORMED SUBMISSION TYPE**: CERT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260128

**DATE AS OF CHANGE**: 20260128

**EFFECTIVENESS DATE**: 20260128

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Polaryx Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0002075320
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** WY
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CERT
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43080
- **FILM NUMBER:** 26570683

**BUSINESS ADDRESS:**
- **STREET 1:** 140 EAST RIDGEWOOD AVENUE
- **STREET 2:** SUITE 415, SOUTH TOWER
- **CITY:** PARAMUS
- **STATE:** NJ
- **ZIP:** 07652
- **BUSINESS PHONE:** 201-940-7236

**MAIL ADDRESS:**
- **STREET 1:** SOUTH TOWER, 140 E RIDGEWOOD AVENUE
- **STREET 2:** SUITE 415
- **CITY:** PARAMUS
- **STATE:** NJ
- **ZIP:** 07652

### Attached PDF Documents

**Attachment 1:** `PLYX_8A_Cert_2075320.pdf`

_No text found in this document._